<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To detect the relationship between sensitivity of malignant hematopoietic cells to <z:chebi fb="0" ids="30621">arsenic trioxide</z:chebi> (<z:chebi fb="0" ids="30621">As2O3</z:chebi>) and cellular capacity against oxidation </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Nine cell lines derived from <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e> were treated with <z:chebi fb="0" ids="30621">As2O3</z:chebi> in vitro </plain></SENT>
<SENT sid="2" pm="."><plain><z:mpath ids='MPATH_3'>Apoptosis</z:mpath> was assessed by cellular viability, cytomorphology and flow cytometry </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:chebi fb="0" ids="30621">As2O3</z:chebi>-treated cells were examined for <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH) level and activity of catalase (CAT), <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD), <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase (GST) and <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GPX) </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Of the 9 cell lines examined, the <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> cell line NB4 and its <z:chebi fb="2" ids="26536">retinoic acid</z:chebi>-resistant subclones R2 and MR2, the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line Namalwa and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> cell line RPMI 8226 were sensitive to <z:chebi fb="0" ids="30621">As2O3</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> while the <z:hpo ids='HP_0011009'>acute</z:hpo> T cell <z:hpo ids='HP_0001909'>leukemia</z:hpo> cell line (Jurkat) and 3 cell lines (<z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60, U937, K562) of myelogenous <z:hpo ids='HP_0001909'>leukemia</z:hpo> origin were not </plain></SENT>
<SENT sid="5" pm="."><plain>In comparison with the sensitive cell lines, higher activity of CAT was found in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 and U937, higher level of GSH in Jurkat, and both in K562 </plain></SENT>
<SENT sid="6" pm="."><plain>However, activity of GPX, GST and SOD did not significantly correlate with their resistance to <z:chebi fb="0" ids="30621">As2O3</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Intracellular GSH level and/or catalase activity are important factors to determine sensitivity of malignant hematopoietic cells to <z:chebi fb="0" ids="30621">As2O3</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>